Older adults experiencing irreversible blindness may now be able to see thanks to a system relying on a wireless retinal implant and high-tech glasses ...

The manuscript concerns a fundamental and controversial question in Trypanosoma brucei biology and the parasite life cycle, providing further evidence that slender bloodstream forms can indeed infect ...

According to Nova One Advisor, the global genomics data analysis market size is calculated at USD 7.91 billion in 2025 and is ...

The headline numbers for Illumina (ILMN) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street ...

About Vaxxas Vaxxas is a biotechnology company pioneering a needle-free vaccination technology designed to enhance immune response, reduce costs, and improve accessibility. The company recently ...

DeciBio Consulting LLC, a leading market intelligence and strategy consulting firm, announced the publication of its first edition, "Proteomics Tools Report: Research and Clinical markets (2025-2030).

In participants with geographic atrophy due to age-related macular degeneration, a photovoltaic retina implant microarray (PRIMA) system leads to significant improvement in visual acuity.

Geographic atrophy, an advanced form of dry age-related macular degeneration, leaves almost five million people around the ...

A photovoltaic retinal implant shows promise as a way to improve vision in patients with advanced age-related macular ...